Romain Colle Selected Research

2- (4- methyl- 2- thiazolylazo)- 5- diethylaminophenol

1/2020	Severe insomnia is associated with metabolic syndrome in women over 50 years with major depression treated in psychiatry settings: a METADAP report.
12/2018	Early weight gain predicts later metabolic syndrome in depressed patients treated with antidepressants: Findings from the METADAP cohort.
12/2018	Early weight gain predicts later weight gain in depressed patients treated with antidepressants: Findings from the METADAP cohort.
1/2018	The TRKB rs2289656 genetic polymorphism is associated with acute suicide attempts in depressed patients: A transversal case control study.
1/2017	Severe insomnia is associated with hypertriglyceridemia in women with major depression treated in psychiatry settings.
10/2015	Treating major depressive episodes with antidepressants can induce or worsen metabolic syndrome: results of the METADAP cohort.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Romain Colle Research Topics

Disease

19	Major Depressive Disorder (Major Depressive Disorders) 10/2020 - 10/2014
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020 - 10/2015
3	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2020 - 01/2017
2	Weight Gain 12/2018 - 12/2018
2	Overweight 12/2018 - 12/2018
1	COVID-19 03/2022
1	Occupational Stress 01/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2021
1	Fatigue 01/2021
1	Hypertriglyceridemia 01/2020
1	Neoplasms (Cancer) 01/2020
1	Schizophrenia (Dementia Praecox) 10/2019
1	Insulin Resistance 10/2019
1	Methemoglobinemia 01/2019
1	Mania (Manias) 01/2019
1	Hypertension (High Blood Pressure) 12/2018
1	Alcoholism (Alcohol Abuse) 01/2017
1	Type 2 Diabetes Mellitus (MODY) 01/2017
1	Disease Progression 01/2017
1	Infections 01/2016
1	Heart Failure 01/2016
1	Substance-Related Disorders (Drug Abuse) 01/2016
1	Liver Diseases (Liver Disease) 01/2016
1	Non-alcoholic Fatty Liver Disease 01/2016
1	Neurobehavioral Manifestations 11/2014

Drug/Important Bio-Agent (IBA)

16	Antidepressive Agents (Antidepressants)IBA 10/2021 - 04/2015
12	3,4-methylenedioxyethamphetamine (MDEA)IBA 10/2020 - 02/2015
6	2- (4- methyl- 2- thiazolylazo)- 5- diethylaminophenolIBA 01/2020 - 10/2015
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2017
4	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2019 - 04/2015
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2022
1	AnticoagulantsIBA 03/2022
1	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2022
1	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 10/2020
1	Pharmaceutical PreparationsIBA 10/2020
1	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 10/2020
1	Superoxides (Superoxide)IBA 03/2020
1	AnionsIBA 03/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	Dapsone FDA Link 01/2019
1	insulin receptor-related receptor (IRR)IBA 12/2018
1	Glucose (Dextrose)FDA LinkGeneric 12/2018
1	Indicators and Reagents (Reagents)IBA 12/2018
1	Glycogen Synthase (Synthase I)IBA 11/2018
1	Proteins (Proteins, Gene)FDA Link 11/2018
1	Transcription Factors (Transcription Factor)IBA 01/2017
1	Pioglitazone (Actos)FDA Link 01/2017
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2017
1	PPAR gammaIBA 01/2017
1	Transaminases (Aminotransferases)IBA 01/2016
1	Serotonin (5 Hydroxytryptamine)IBA 01/2016
1	valylvaline (Val-Val)IBA 04/2015
1	Serotonin and Noradrenaline Reuptake InhibitorsIBA 04/2015
1	VortioxetineIBA 11/2014
1	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 10/2014

Therapy/Procedure

1	Therapeutics 03/2022
1	Ambulatory Care (Outpatient Care) 01/2021